TEPLIZUMAB-MZWV

TEPLIZUMAB-MZWV was reported 720 times

These side effects are most commonly reported by patients taking TEPLIZUMAB-MZWV:

# Side effect Count
0 RASH 166
1 NAUSEA 139
2 PYREXIA 120
3 FATIGUE 119
4 VOMITING 92
5 HEADACHE 86
6 LYMPHOPENIA 62
7 LYMPHOCYTE COUNT DECREASED 55
8 CHILLS 51
9 RASH PRURITIC 44
10 PAIN 42
11 PRURITUS 41
12 ALANINE AMINOTRANSFERASE INCREASED 35
13 DIARRHOEA 34
14 WHITE BLOOD CELL COUNT DECREASED 34
15 ASPARTATE AMINOTRANSFERASE INCREASED 30
16 HEPATIC ENZYME INCREASED 26
17 CYTOKINE RELEASE SYNDROME 25
18 RASH ERYTHEMATOUS 23
19 LIVER FUNCTION TEST INCREASED 22
20 HYPOTENSION 20
21 BLOOD GLUCOSE INCREASED 19
22 DIZZINESS 19
23 MALAISE 19
24 MYALGIA 19
25 DECREASED APPETITE 18
26 INFLUENZA LIKE ILLNESS 18
27 OFF LABEL USE 18
28 URTICARIA 18
29 CONDITION AGGRAVATED 17
30 HYPERGLYCAEMIA 15
31 PERIPHERAL SWELLING 15
32 ARTHRALGIA 14
33 DYSPNOEA 14
34 BACK PAIN 13
35 BODY TEMPERATURE INCREASED 13
36 LYMPHOCYTE COUNT ABNORMAL 13
37 OROPHARYNGEAL PAIN 13
38 PLATELET COUNT DECREASED 13
39 SOMNOLENCE 13
40 ASTHENIA 11
41 CHEST DISCOMFORT 11
42 FEELING COLD 11
43 FLUSHING 11
44 LYMPHADENOPATHY 11
45 SKIN SWELLING 11
46 TACHYCARDIA 11
47 ABDOMINAL PAIN UPPER 10
48 BLOOD GLUCOSE DECREASED 10
49 CHEST PAIN 10
50 CONSTIPATION 10
51 DEHYDRATION 10
52 HEART RATE INCREASED 10
53 INCORRECT DOSE ADMINISTERED 10
54 ERYTHEMA 9
55 LEUKOPENIA 9
56 RASH MACULAR 9
57 SKIN EXFOLIATION 9
58 DRY SKIN 8
59 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 8
60 NEUTROPHIL COUNT DECREASED 8
61 PARAESTHESIA 8
62 PRODUCT PREPARATION ERROR 8
63 ABDOMINAL DISCOMFORT 7
64 BLOOD BILIRUBIN INCREASED 7
65 BLOOD PRESSURE INCREASED 7
66 INFUSION SITE ERYTHEMA 7
67 ABDOMINAL PAIN 6
68 GLYCOSYLATED HAEMOGLOBIN INCREASED 6
69 NASOPHARYNGITIS 6
70 RASH PAPULAR 6
71 THROMBOCYTOPENIA 6
72 TREMOR 6
73 ANXIETY 5
74 BLISTER 5
75 BLOOD PRESSURE DECREASED 5
76 BRAIN FOG 5
77 CONFUSIONAL STATE 5
78 COUGH 5
79 ECZEMA 5
80 FEELING ABNORMAL 5
81 HYPERHIDROSIS 5
82 ILLNESS 5
83 INFUSION SITE PRURITUS 5
84 PHARYNGITIS STREPTOCOCCAL 5
85 RASH MACULO-PAPULAR 5
86 SWELLING 5
87 TRANSAMINASES INCREASED 5
88 DRUG INEFFECTIVE 4
89 FALL 4
90 FEELING HOT 4
91 HAEMOGLOBIN DECREASED 4
92 HYPERTENSION 4
93 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4
94 INFUSION SITE RASH 4
95 INSOMNIA 4
96 LETHARGY 4
97 MIGRAINE 4
98 NECK PAIN 4
99 PALLOR 4
100 SWELLING FACE 4
101 VISION BLURRED 4
102 BLOOD ALKALINE PHOSPHATASE INCREASED 3
103 BLOOD GLUCOSE ABNORMAL 3
104 BLOOD GLUCOSE FLUCTUATION 3
105 BURNING SENSATION 3
106 DEEP VEIN THROMBOSIS 3
107 DISCOMFORT 3
108 DYSPHAGIA 3
109 EAR PAIN 3
110 EPISTAXIS 3
111 GASTROINTESTINAL DISORDER 3
112 GASTROOESOPHAGEAL REFLUX DISEASE 3
113 HYPERSENSITIVITY 3
114 HYPERTRANSAMINASAEMIA 3
115 HYPOAESTHESIA 3
116 INFLUENZA 3
117 INFUSION SITE PAIN 3
118 JAUNDICE 3
119 LOSS OF CONSCIOUSNESS 3
120 NEUTROPENIA 3
121 NIGHT SWEATS 3
122 PAIN IN EXTREMITY 3
123 PHARYNGEAL SWELLING 3
124 PLATELET COUNT ABNORMAL 3
125 PRESYNCOPE 3
126 RHINORRHOEA 3
127 SKIN BURNING SENSATION 3
128 SYNCOPE 3
129 TONSILLITIS 3
130 WHITE BLOOD CELL COUNT ABNORMAL 3
131 WHITE BLOOD CELL COUNT INCREASED 3
132 ACCIDENTAL OVERDOSE 2
133 APHTHOUS ULCER 2
134 ASPARTATE AMINOTRANSFERASE DECREASED 2
135 AXILLARY PAIN 2
136 CATHETER SITE PAIN 2
137 CELLULITIS 2
138 CONJUNCTIVITIS 2
139 CRYING 2
140 DEVICE RELATED INFECTION 2
141 DIABETES MELLITUS 2
142 DIABETIC KETOACIDOSIS 2
143 DOSE CALCULATION ERROR 2
144 DYSPEPSIA 2
145 DYSSTASIA 2
146 DYSURIA 2
147 EPSTEIN-BARR VIRUS ANTIBODY POSITIVE 2
148 EXFOLIATIVE RASH 2
149 EYELID RASH 2
150 FEEDING DISORDER 2
151 FLATULENCE 2
152 FULL BLOOD COUNT DECREASED 2
153 GENITAL RASH 2
154 GLASSY EYES 2
155 GLOSSODYNIA 2
156 HEAD DISCOMFORT 2
157 HEPATOTOXICITY 2
158 HYPERKALAEMIA 2
159 HYPERSOMNIA 2
160 HYPOCHLORAEMIA 2
161 HYPOGLYCAEMIA 2
162 HYPONATRAEMIA 2
163 INCORRECT DRUG ADMINISTRATION RATE 2
164 INCORRECT PRODUCT ADMINISTRATION DURATION 2
165 INFECTIOUS MONONUCLEOSIS 2
166 INFLUENZA A VIRUS TEST POSITIVE 2
167 INFUSION RELATED REACTION 2
168 INFUSION SITE BRUISING 2
169 INFUSION SITE IRRITATION 2
170 INJECTION SITE PAIN 2
171 LIMB DISCOMFORT 2
172 LIVER DISORDER 2
173 LIVER FUNCTION TEST ABNORMAL 2
174 MEMORY IMPAIRMENT 2
175 MUSCULAR WEAKNESS 2
176 MUSCULOSKELETAL CHEST PAIN 2
177 NEUTROPHIL COUNT INCREASED 2
178 OEDEMA PERIPHERAL 2
179 PALPITATIONS 2
180 PERIORBITAL OEDEMA 2
181 PNEUMONIA 2
182 PRODUCT DOSE OMISSION ISSUE 2
183 PRODUCT PREPARATION ISSUE 2
184 PRODUCT PRESCRIBING ISSUE 2
185 PRODUCT USE IN UNAPPROVED INDICATION 2
186 RASH VESICULAR 2
187 RED BLOOD CELL COUNT DECREASED 2
188 SENSITIVE SKIN 2
189 SKIN EROSION 2
190 SKIN LESION 2
191 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2
192 THERAPY CESSATION 2
193 THROAT IRRITATION 2
194 THROAT TIGHTNESS 2
195 THROMBOSIS 2
196 UNRESPONSIVE TO STIMULI 2
197 UPPER RESPIRATORY TRACT INFECTION 2
198 VEIN DISORDER 2
199 VEIN RUPTURE 2
200 WHITE BLOOD CELL DISORDER 2
201 ABDOMINAL PAIN LOWER 1
202 ACANTHOSIS 1
203 ALANINE AMINOTRANSFERASE ABNORMAL 1
204 ALANINE AMINOTRANSFERASE DECREASED 1
205 AMENORRHOEA 1
206 AMNESIA 1
207 ANAEMIA 1
208 ANAPHYLACTIC REACTION 1
209 APNOEA 1
210 ARACHNOID CYST 1
211 ARTHRITIS 1
212 ARTHROPOD BITE 1
213 ASPARTATE AMINOTRANSFERASE ABNORMAL 1
214 ASTHMA 1
215 BACTERIAL INFECTION 1
216 BASOPHILIA 1
217 BEHAVIOUR DISORDER 1
218 BLOOD ALKALINE PHOSPHATASE DECREASED 1
219 BLOOD BILIRUBIN ABNORMAL 1
220 BLOOD CALCIUM DECREASED 1
221 BLOOD CHOLESTEROL INCREASED 1
222 BLOOD CREATININE INCREASED 1
223 BLOOD FIBRINOGEN ABNORMAL 1
224 BLOOD LACTATE DEHYDROGENASE ABNORMAL 1
225 BLOOD LACTIC ACID INCREASED 1
226 BLOOD PRESSURE ABNORMAL 1
227 BLOOD PRESSURE FLUCTUATION 1
228 BLOOD PRESSURE SYSTOLIC DECREASED 1
229 BLOOD PRESSURE SYSTOLIC INCREASED 1
230 BLOOD TEST ABNORMAL 1
231 BLOOD UREA INCREASED 1
232 BODY TEMPERATURE DECREASED 1
233 BONE PAIN 1
234 BRONCHOSPASM 1
235 C-REACTIVE PROTEIN ABNORMAL 1
236 CANDIDA INFECTION 1
237 CAPILLARY DISORDER 1
238 CARDIO-RESPIRATORY ARREST 1
239 CARPAL TUNNEL SYNDROME 1
240 CATARACT SUBCAPSULAR 1
241 CATHETER SITE DISCOLOURATION 1
242 CATHETER SITE SWELLING 1
243 CATHETER SITE THROMBOSIS 1
244 CHROMATURIA 1
245 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1
246 COGNITIVE DISORDER 1
247 COLD SWEAT 1
248 CONCUSSION 1
249 CORNEAL REFLEX DECREASED 1
250 COVID-19 1
251 CUBITAL TUNNEL SYNDROME 1
252 CYANOSIS 1
253 DERMATITIS CONTACT 1
254 DEVICE LEAKAGE 1
255 DEVICE RELATED SEPSIS 1
256 DEVICE RELATED THROMBOSIS 1
257 DIABETES MELLITUS INADEQUATE CONTROL 1
258 DISSEMINATED INTRAVASCULAR COAGULATION 1
259 DRUG HYPERSENSITIVITY 1
260 DRUG MONITORING PROCEDURE NOT PERFORMED 1
261 DRY EYE 1
262 EMOTIONAL DISORDER 1
263 EOSINOPHILIA 1
264 EPSTEIN-BARR VIRUS TEST POSITIVE 1
265 ESCHERICHIA INFECTION 1
266 EXTRA DOSE ADMINISTERED 1
267 EYE MOVEMENT DISORDER 1
268 EYELIDS PRURITUS 1
269 FACIAL DISCOMFORT 1
270 FEAR OF INJECTION 1
271 FEBRILE NEUTROPENIA 1
272 FEELING OF BODY TEMPERATURE CHANGE 1
273 FIBRIN D DIMER INCREASED 1
274 FLUID RETENTION 1
275 FOOD INTOLERANCE 1
276 FULL BLOOD COUNT ABNORMAL 1
277 FULL BLOOD COUNT INCREASED 1
278 FUNGAL SKIN INFECTION 1
279 GASTROENTERITIS ESCHERICHIA COLI 1
280 GASTROINTESTINAL INFECTION 1
281 GENERALISED OEDEMA 1
282 HAEMATOCHEZIA 1
283 HAEMATOCRIT DECREASED 1
284 HAEMATOCRIT INCREASED 1
285 HANGOVER 1
286 HEAD INJURY 1
287 HEPATIC ENZYME ABNORMAL 1
288 HERPES ZOSTER 1
289 HOT FLUSH 1
290 HYPOAESTHESIA ORAL 1
291 HYPOCALCAEMIA 1
292 INFLAMMATION 1
293 INFLUENZA VIRUS TEST POSITIVE 1
294 INFUSION SITE EXTRAVASATION 1
295 INFUSION SITE SCAR 1
296 INJECTION SITE DISCOLOURATION 1
297 INJECTION SITE ERYTHEMA 1
298 INJECTION SITE PRURITUS 1
299 INJECTION SITE REACTION 1
300 INSULIN THERAPY 1
301 INTENTIONAL DOSE OMISSION 1
302 INTERCEPTED PRODUCT ADMINISTRATION ERROR 1
303 IRRITABILITY 1
304 JOINT SWELLING 1
305 KETONURIA 1
306 LABORATORY TEST ABNORMAL 1
307 LEUKOCYTE VACUOLISATION 1
308 LIP DRY 1
309 LIP SWELLING 1
310 LYMPH NODE PAIN 1
311 LYMPHATIC DISORDER 1
312 LYMPHOCYTE COUNT INCREASED 1
313 LYMPHOCYTE MORPHOLOGY ABNORMAL 1
314 MICROALBUMINURIA 1
315 MIDDLE INSOMNIA 1
316 MOBILITY DECREASED 1
317 MONOCYTE COUNT DECREASED 1
318 MOOD ALTERED 1
319 MUSCLE SPASMS 1
320 MUSCULOSKELETAL PAIN 1
321 MUSCULOSKELETAL STIFFNESS 1
322 NASAL CONGESTION 1
323 NEUTROPHIL COUNT ABNORMAL 1
324 NIGHT BLINDNESS 1
325 NO ADVERSE EVENT 1
326 NONINFECTIVE SIALOADENITIS 1
327 ORAL DISORDER 1
328 ORAL FUNGAL INFECTION 1
329 ORAL HERPES 1
330 OROPHARYNGEAL DISCOMFORT 1
331 OROPHARYNGEAL PLAQUE 1
332 OVARIAN FAILURE 1
333 OVERDOSE 1
334 PAIN IN JAW 1
335 PALMAR ERYTHEMA 1
336 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1
337 PAPULE 1
338 PERIORBITAL SWELLING 1
339 PERIPHERAL COLDNESS 1
340 PHARYNGITIS 1
341 PHYSICAL PRODUCT LABEL ISSUE 1
342 PLATELET COUNT INCREASED 1
343 POSTPRANDIAL HYPOGLYCAEMIA 1
344 PREMATURE MENOPAUSE 1
345 PRODUCT ADMINISTRATION INTERRUPTED 1
346 PRODUCT ADVERTISING ISSUE 1
347 PRODUCT DESIGN ISSUE 1
348 PRODUCT DISPENSING ERROR 1
349 PRODUCT NAME CONFUSION 1
350 PRODUCT QUALITY ISSUE 1
351 PRODUCT SELECTION ERROR 1
352 PRODUCT TEMPERATURE EXCURSION ISSUE 1
353 PRODUCT USE ISSUE 1
354 PRODUCTIVE COUGH 1
355 PROTHROMBIN TIME ABNORMAL 1
356 PULMONARY PAIN 1
357 PULSELESS ELECTRICAL ACTIVITY 1
358 RADIUS FRACTURE 1
359 RAYNAUD^S PHENOMENON 1
360 RESPIRATORY TRACT CONGESTION 1
361 RESTLESSNESS 1
362 RETCHING 1
363 SCRATCH 1
364 SEIZURE 1
365 SEIZURE LIKE PHENOMENA 1
366 SENSATION OF FOREIGN BODY 1
367 SENSORY OVERLOAD 1
368 SEPSIS 1
369 SERUM FERRITIN ABNORMAL 1
370 SHOULDER ARTHROPLASTY 1
371 SKIN HAEMORRHAGE 1
372 SKIN LACERATION 1
373 SKIN TIGHTNESS 1
374 SPLENOMEGALY 1
375 STAPHYLOCOCCAL BACTERAEMIA 1
376 STOMATITIS 1
377 STREPTOCOCCAL INFECTION 1
378 STREPTOCOCCUS TEST POSITIVE 1
379 SUNBURN 1
380 SUPERFICIAL VEIN THROMBOSIS 1
381 SWELLING OF EYELID 1
382 SWOLLEN TONGUE 1
383 THERAPEUTIC RESPONSE SHORTENED 1
384 THIRST 1
385 THROAT CLEARING 1
386 THROMBOPHLEBITIS SEPTIC 1
387 TONGUE ULCERATION 1
388 TONSILLAR HYPERTROPHY 1
389 TYPE 1 DIABETES MELLITUS 1
390 UNDERDOSE 1
391 UPPER-AIRWAY COUGH SYNDROME 1
392 VIRAL INFECTION 1
393 VISUAL FIELD DEFECT 1
394 VOMITING PROJECTILE 1
395 YERSINIA INFECTION 1